The treatment of uveitic cystoid macular edema with topical Interferon gamma
局部干扰素γ治疗葡萄膜炎性黄斑囊样水肿
基本信息
- 批准号:8938335
- 负责人:
- 金额:$ 14.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Angiogenic FactorAnteriorBathingBiological AssayBlood capillariesCell SurvivalCellsCorneaCystoid Macular EdemaDiseaseDropsEdemaEndothelial CellsEquilibriumEyeEyedropsFluoresceinHourHumanHydration statusImageImmune systemIn VitroInflammationInflammatoryInterferon Type IIInterferonsInterleukin-6Liquid substanceMeasuresOptical Coherence TomographyPathogenesisPathway interactionsPatientsPhosphate BufferPhysiologic Intraocular PressurePlayResistanceRetinalRetinal DetachmentRodent ModelRoleSalineSecondary toSeriesSideSignal Transduction PathwayStaining methodStainsStructure of retinal pigment epitheliumSurfaceTestingTherapeutic EffectThickTimeTissuesToxic effectUveitisVisual Acuityabsorptionangiogenesisbody systemcapillarycell growthconjunctivacytokinein vivoirritationmaculamonolayerocular surfaceprimary outcomereceptorresearch studyresponsesecondary outcome
项目摘要
We hypothesize that proper retinal hydration is maintained by a balance of the bimodal functions of interferon gamma on the retinal pigment epithelium. Mounting evidence strongly suggests that the immune system plays an important role in angiogenesis. Pro-inflammatory cytokines, such as IFNg, IL-6, TNFa and IL-1b are the major cytokines in the pathogenesis of ocular inflammatory diseases and been shown to have receptors on RPE. TNFa, IL-6 and IL-1b are regarded as pro-angiogenic factors. However, IFNg is widely accepted as an anti-angiogenic cytokine due to its inhibitory effect on endothelial cell growth and capillary formation in other organ systems. We have evaluated the effect of interferon gamma on the JAK/STAT pathway, a signal transduction pathway also present in Human RPE cells. Fluid transport assays were performed to examine whether IFN induced changes in fluid transport across hfRPE monolayers. IFNg (10 ng/ml) addition to the basal bath increased JV by 8.6 ulcm-2hr-1, reflecting an increase in fluid absorption from the retinal to the choroidal side of the tissue. There were no apparent changes in cell viability as measured by transepithelial potential (TEP) and total tissue resistance (RT). In 10 experiments, the mean JV increased from 12.9 +/- 1.6 to 20.5 +/- 3.1 uL*cm-2*hr-1 (mean +/- s.e.m., P< 0.01). A previously tested in vivo rodent model of retinal detachment was used to measure the effect of INFg on re-absorption following retinal detachment. Initial detachment was created by injecting approximately 1ul of osmotically-balanced, modified phosphate-buffered saline (MPBS) solution into the sub-retinal space (SRS). Detachments that did not change in volume more than 10% in the first 30 minutes were used to test INFg effects. After detachment stabilization volume was measured by OCT imaging, INFg (40ul of 100ng/ml) was added to the anterior surface of the eye via eye drops (Celluvisc). A series of 3D OCT images were recorded at different time point. Addition of INFg to the anterior eye surface caused a significant, rapid 50% decrease in retinal detachment volume in the first hour of observation. This result is consistent with the observed fluid transport increase in RPE cells in vitro. We hypothesize that in the normal RPE cell, both pathways are functioning simultaneously to maintain the normal retinal hydration. The Jak/Stat pathway, if stimulated from basal side, will induce fluid absorption to resolve the abnormal accumulation of edema. Therefore using INFg can provide therapeutic effect to reverse pathological changes associated with uveitis.
我们假设适当的视网膜水合作用是由干扰素γ在视网膜色素上皮上的双峰功能的平衡维持的。越来越多的证据有力地表明,免疫系统在血管生成中起着重要作用。促炎细胞因子如IFNg、IL-6、TNFa和IL-1b是眼部炎性疾病发病的主要细胞因子,并在RPE上有受体。tnf、IL-6和IL-1b被认为是促血管生成因子。然而,IFNg被广泛认为是一种抗血管生成的细胞因子,因为它对其他器官系统的内皮细胞生长和毛细血管形成有抑制作用。我们已经评估了干扰素γ对JAK/STAT通路的影响,这是一种同样存在于人RPE细胞中的信号转导通路。进行了流体输运试验,以检查ifn是否诱导了hfRPE单层间流体输运的变化。基础液中添加IFNg (10 ng/ml)可使JV增加8.6 ulcm-2hr-1,反映了从视网膜到组织脉络膜侧的液体吸收增加。经上皮电位(TEP)和总组织阻力(RT)测定细胞活力无明显变化。10个实验中,平均JV由12.9 +/- 1.6增加到20.5 +/- 3.1 uL*cm-2*hr-1(平均值+/- s.e.m., P< 0.01)。采用先前测试过的视网膜脱离啮齿动物体内模型来测量INFg对视网膜脱离后再吸收的影响。通过向视网膜下间隙(SRS)注射约1ul渗透压平衡的改性磷酸盐缓冲盐水(MPBS)溶液,形成初始脱离。在前30分钟内体积变化不超过10%的分离体被用来测试INFg效应。在OCT成像测量脱离稳定体积后,通过滴眼液(Celluvisc)将40ul / 100ng/ml的INFg加入眼前表面。记录不同时间点的一系列三维OCT图像。在观察的第一个小时内,在眼前表面添加INFg导致视网膜脱离体积显著迅速减少50%。这一结果与体外观察到的RPE细胞液体转运增加一致。我们假设在正常的RPE细胞中,这两种途径同时起作用以维持正常的视网膜水合作用。如果从基底侧刺激Jak/Stat通路,将诱导液体吸收,以解决水肿的异常积聚。因此,应用纤维蛋白对逆转葡萄膜炎相关病理改变具有一定的治疗作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sheldon Miller其他文献
Sheldon Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sheldon Miller', 18)}}的其他基金
The treatment of uveitic cystoid macular edema with topical Interferon gamma
局部干扰素γ治疗葡萄膜炎性黄斑囊样水肿
- 批准号:
7968430 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
Human Retinal Pigment Epithelial Cell Cultures: Physiology & Fluid Transport
人视网膜色素上皮细胞培养:生理学
- 批准号:
7968352 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
Biological function microRNAs enriched in RPE: in vitro and in vivo models
RPE 中富集的生物学功能 microRNA:体外和体内模型
- 批准号:
7968404 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
Protective effects of neurotrophic factors on RPE physiology
神经营养因子对 RPE 生理的保护作用
- 批准号:
7968410 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
AG13764 and AG13711 Reverses VEGF-Induced Choroidal Neovascularization in Rat Eye
AG13764 和 AG13711 逆转 VEGF 诱导的大鼠眼脉络膜新生血管形成
- 批准号:
7968355 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
Lactate transport and pH-regulation in the human RPE
人类 RPE 中的乳酸转运和 pH 调节
- 批准号:
7734651 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
pH-dependent ion- transport mechanism in the hfRPE
hfRPE 中 pH 依赖性离子传输机制
- 批准号:
8149180 - 财政年份:
- 资助金额:
$ 14.06万 - 项目类别:
相似海外基金
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Anterior Insula Projections for Alcohol Drinking/Anxiety Interactions in Female and Male Rats
雌性和雄性大鼠饮酒/焦虑相互作用的前岛叶预测
- 批准号:
10608759 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Fear and anxiety circuit mechanisms in anterior hypothalamic nucleus
下丘脑前核的恐惧和焦虑环路机制
- 批准号:
10789153 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Elucidating signaling networks in Anterior Segment development, repair and diseases
阐明眼前节发育、修复和疾病中的信号网络
- 批准号:
10718122 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary
圆锥角膜、性激素和垂体前叶之间的密切相互作用
- 批准号:
10746247 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immunepathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10804810 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Investigation of the effect of anterior eye shape on myopia progression due to prolonged near work.
研究因长时间近距离工作而导致的前眼形状对近视进展的影响。
- 批准号:
23K09063 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation and characterization of anterior pituitary stem cells from human pluripotent stem cells
人多能干细胞垂体前叶干细胞的产生和表征
- 批准号:
23K08005 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anterior cruciate ligament injury: towards a gendered environmental approach
前十字韧带损伤:走向性别环境方法
- 批准号:
485090 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Operating Grants
EASI-TOC: Endovascular Acute Stroke Intervention-Tandem OCclusion: atrial of acute cervical internal carotid artery stenting during endovascularthrombectomy for anterior circulation stroke
EASI-TOC:血管内急性卒中干预-串联闭塞:前循环卒中血管内血栓切除术期间急性颈内动脉心房支架置入术
- 批准号:
490056 - 财政年份:2023
- 资助金额:
$ 14.06万 - 项目类别:
Operating Grants














{{item.name}}会员




